To define the role of endogenous Mer expression in dictating the sensitivity of NSCLC cells to EGFR inhibitor, we selected H1965 cells harboring EGFR mutation (delE746-A750) which is insensitive to erlotinib treatment and express the high level of endogenous Mer. This evidence concerns the gene MERTK and non-small cell lung carcinoma.